TrialDrugs & aging2018

Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures.

Raquel Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.